Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

Completed · Phase 2

Conditions studied: HIV Infections

In brief

This trial tests the safety and effectiveness of the early use of combinations of anti-HIV drugs in HIV-infected infants and young children in an effort to block virus growth and preserve normal immune functions. Various anti-HIV drug combinations need to be tested in order to find the best way to treat infants and children who have been infected with HIV during birth.

Key facts

Study ID
NCT00000872
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
55
Expected to finish
2005-01-01
Last updated by the study team
2021-11-04

Who can join

Age: 0 and older, up to 2. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.